A Study to Evaluate the Safety and Immunogenicity of A/California/7/2009 (H1N1)V-like Vaccines GSK2340273A and GSK2340274A in Adults Aged 18 Years and Older.
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2017
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary) ; AS03A; AS03B
- Indications Influenza A virus H1N1 subtype
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 01 Mar 2012 Results published in the Journal of Infectious Diseases.
- 23 Dec 2010 Actual end date changed from Nov 2010 to Dec 2010 as reported by ClinicalTrials.gov.
- 10 Dec 2010 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.